Project Grant HT94252510066
Award Date
3/1/25
Completion Date
2/29/28
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Fort Collins, CO 80521, USA
Similar Awards
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
This $2,134,174 Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to the Metis Foundation supports the development of a "sprayable antimicrobial and regeneration promoting foam scaffold for the treatment of non-healing skin wounds." The grant has an award date of September 1, 2023 and a completion date of August 31, 2027. The Metis Foundation, a non-profit organization that supports innovative medical research and education for...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The U.S. Department of Defense's Defense Health Agency has awarded a $902,109 Project Grant to North Carolina State University (NC State) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," supports the development of advanced nanoparticle-based technologies to improve hemorrhage control at the point of injury. The award period runs from July 1, 2024 to...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,000,000.00 in funding to Medcura, Inc. in Riverdale, MD to expand the development and production of a biopolymer powder treatment for noncompressible torso hemorrhage. The research aims to improve health outcomes for military service members and the broader public by advancing this innovative medical technology. The award period extends from Aug 5,...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $2,200,000 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The award, with an effective date of Sep 30, 2023 and ultimate completion date of Sep 29, 2026, will fund research focused on "Prevention and Treatment of Frostbite Infection with Antimicrobial Pharmacokinetic Analysis" to be conducted at the University's...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...